CureAll Pharma is considering whether to make an investment in a new type of vaccine. Which of the following factors should the company consider when it decides whether to undertake the investment?

Factor A: The company already spent $4 million on Phase 3 trials to get regulatory approval for the new vaccine

Factor B: The media coverage for the new vaccine will increase sales of some of the firm's existing products

Factor C: The firm will finance the project by selling its government bond holdings which currently yield 5%

Group of answer choices

A,B,C

B,C only

B only

A,B only

None of these alternatives